Literature DB >> 1260756

Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.

H D Suit, R Sedlacek, M Wagner, L Orsi, V Silobrcic, K J Rothman.   

Abstract

A methylcholanthrene-induced fibrosarcoma of C3H mice has been used as 5th- to 6th-generation syngeneic transplant in an investigation of the role of Corynebacterium parvum as an adjuvant to the therapeutic effect of local irradiation of established tumors. The most effective route for administration of C. parvum in this tumor system was i.v., and the greatest effect of the C. parvum-mediated tumor graft rejection was observed for tumor growing intracutaneously or s.c. An intermediate level of effectiveness was obtained for tumor growing i.m. The combined C. parvum and local irradiation studies were performed using tumors growing in the leg muscle and measuring 8 mm in diameter at the time of local irradiation. Several routes of administration of C. parvum, dose levels of C. parvum, and time relationships between administration of C. parvum and irradiation were investigated. The outstanding finding was that very low doses of radiation were quite effective when administered to tumors growing in animals pretreated with C. parvum. This was true for radiation administered as a single or fractionated dose (10 equal doses spread over 18 days). For single-dose irradiation the effect was relatively dose independent over the range of 200 to 3000 rads. Some indication was obtained that local irradiation may impair the tumor graft rejection reaction. No evidence was obtained of an enhanced growth of tumor. Regression of tumor following irradiation was not modified by pretreatment with C. parvum. The mice that were unsuccessfully treated by radiation and C. parvum had a lower incidence of metastatic disease in the lung than did the mice treated unsuccessfully with radiation alone.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1260756

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Sickness behavior induced by cisplatin chemotherapy and radiotherapy in a murine head and neck cancer model is associated with altered mitochondrial gene expression.

Authors:  Elisabeth G Vichaya; Jessica M Molkentine; Daniel W Vermeer; Adam K Walker; Rebekah Feng; Gerard Holder; Katherine Luu; Ryan M Mason; Leo Saligan; Cobi J Heijnen; Annemieke Kavelaars; Kathy A Mason; John H Lee; Robert Dantzer
Journal:  Behav Brain Res       Date:  2015-10-22       Impact factor: 3.332

2.  Immune adjuvants for chemotherapy or radiotherapy in the 9L rat brain tumor model.

Authors:  C Liu; B F Kimler; R G Evans; R A Morantz
Journal:  J Neurooncol       Date:  1993-02       Impact factor: 4.130

3.  Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma.

Authors:  J A Nelson; J A Hokanson; V K Jenkins
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  Neuroimmune mechanisms of behavioral alterations in a syngeneic murine model of human papilloma virus-related head and neck cancer.

Authors:  Elisabeth G Vichaya; Daniel W Vermeer; Diana L Christian; Jessica M Molkentine; Kathy A Mason; John H Lee; Robert Dantzer
Journal:  Psychoneuroendocrinology       Date:  2017-02-11       Impact factor: 4.905

5.  Immune reaction of tumor-bearing mice to Propionibacterium acnes and the antitumor effect of the bacteria.

Authors:  V Silobrcic; G Fredrickson; R Sedlacek; H D Suit; G Wolberg
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

6.  Variability of tumor response to chemotherapy. II. Contribution of tumor heterogeneity.

Authors:  L Simpson-Herren; P E Noker; S D Wagoner
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 7.  A Century of Radiation Therapy and Adaptive Immunity.

Authors:  Dörthe Schaue
Journal:  Front Immunol       Date:  2017-04-11       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.